A Phase 2 Study To Evaluate The Safety And Effect Of Study Drug On Proteinuria In Subjects With Iga Nephropathy, Lupus Nephritis, Membranous Nephropa
Posted Date: May 15, 2019
- Investigator: Mahmoud El-Khatib
- Type of Study: Drug
The purpose of this study is to test the safety and describe the effect of OMS721, an ?investigational drug?, in people with these types of kidney diseases or glomerulonephropathies. ?Investigational drug? means that the drug has not been approved for sale in the United States by the U.S. Food and
Criteria:
You Are Being Asked To Consider Being In This Study Because You Have One Of These Specific Types Of
Keywords:
Membranous Nephropat, Proteinuria, Lupus Nephritis, C3 Glomerulopathy, Iga Nephropathy
For More Information:
Karen Case
(513) 559-3367
karen.case@uc.edu